SMARCA4 and cancer: The localization of BRG1-dependent accessible sites to TSS-distal regions and their cancer cell specificity at the loci level (Figure 2 and Figure 4) prompted us to determine how many BRG1-dependent accessible sites are enhancer regions, which we accomplished through performing chromatin-binding assays for histone proteins to delineate promoters versus enhancers in the genome.